ArticleBMC nephrology2025
A qualitative study of nephrologists' perspectives on implementing a nephrology rapid response model for acute kidney injury.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAcute kidney injury (AKI) poses major health and economic burdens, especially in low-resource settings like Palestine. This study explores nephrologists' perspectives on implementing the Nephrology Rapid Response Team (NRRT) model, highlighting key barriers, facilitators, and strategic priorities to improve AKI care. STUDY
designA qualitative, exploratory study design was employed to gain in-depth nephrologists' perspectives on the feasibility of implementing the Nephrology Rapid Response Team (NRRT) model in Palestinian hospitals.
methodsThirteen board-certified nephrologists were recruited using purposive sampling. Semi-structured interviews were conducted between January and May 2024, with data transcribed verbatim and analyzed thematically using MAXQDA Analytics Pro software. Thematic analysis identified key facilitators, barriers, and recommendations. Rigorous methodological strategies ensured the credibility, dependability, and transferability of the findings.
resultsFive enablers themes emerged that could facilitate integration of the model: strategic backing from the Ministry of Health, a growing orientation toward prevention-driven healthcare policies, enhanced multidisciplinary collaboration with early nephrologist engagement, institutional endorsement through hospital-based systems, and the progressive adoption of technological innovations such as electronic alert systems and novel biomarkers. On the other hand, five dominant barrier themes emerged. These include systemic governance and policy fragmentation, financial and operational limitations, a pronounced shortage of nephrology specialists, insufficient awareness and prevention frameworks, and weak collaboration and surveillance systems-particularly the lack of a national renal registry. Despite these obstacles, nephrologists expressed optimism, offering three central recommendations to support sustainable implementation. These include systemic policy and governance reforms, investments in nephrology education and training programs, and the expansion of public awareness and prevention strategies through primary care engagement. Together, these strategies represent a foundational roadmap for overcoming structural challenges and AKI care delivery through the NRRT model.
conclusionsThis study highlights the Ministry of Health's critical role in leading reforms for NRRT implementation, emphasizing prevention, technology, and capacity-building as priorities to improve nephrology care. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.